Who
Ben Bronstein
Director
Company insider
Files Form 4 as: Director, Aldeyra Therapeutics.
In numbers
- Trades disclosed
- 41
- Buys
- 3
- Sells
- 0
- Bought
- $130K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 7 May 2014
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,309 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,977 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,309 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,977 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,728 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,619 at $0.00 | filing |
| 10 Jun 2024filed 12 Jun 2025 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,860 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,282 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,604 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,222 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,372 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,464 at $0.00 | filing |
| 27 Jun 2023filed 29 Jun 2023 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —9,604 at $0.00 | filing |
| 27 Jun 2023filed 29 Jun 2023 | ALDX Aldeyra TherapeuticsBiotechnology | SEC FORM 4 Code M | $5,2829,604 at $0.55 | filing |
| 7 Jun 2022filed 9 Jun 2022 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —53,812 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,479 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | ALDX Aldeyra Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,711 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.